TARX (Tarsier Pharma) FCF Margin %: 0.00% (As of Dec. 2025)


What is Tarsier Pharma FCF Margin %?

Tarsier Pharma TARX FCF Margin % is 0.00% as of Dec. 2025.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tarsier Pharma's Free Cash Flow for the six months ended in Dec. 2025 was $-0.79 Mil. Tarsier Pharma's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Tarsier Pharma's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Tarsier Pharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Tarsier Pharma's FCF Margin % or its related term are showing as below:


TARX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -82.65
* Ranked among companies with meaningful FCF Margin % only.

Tarsier Pharma FCF Margin % Related Terms

Tarsier Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Tarsier Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsier Pharma FCF Margin % Chart

Tarsier Pharma Annual Data
Trend Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 0.00

Tarsier Pharma Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % 0.00 0.00 0.00 0.00 0.00

TARX vs : FCF Margin % Comparison

For the Biotechnology subindustry, Tarsier Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tarsier Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tarsier Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tarsier Pharma's FCF Margin % falls into.


Tarsier Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tarsier Pharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.319/0
= %

Tarsier Pharma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.787/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Tarsier Pharma (TARX) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tarsier Pharma and its competitors.
Is Tarsier Pharma's FCF Margin % too high?
Tarsier Pharma's current FCF Margin % is 0.00%.
How does Tarsier Pharma's FCF Margin % compare to ?
Tarsier Pharma's FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tarsier Pharma and its competitors. Tarsier Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsier Pharma stock overvalued right now?
Tarsier Pharma (TARX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Tarsier Pharma (TARX), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tarsier Pharma Business Description

Comparable Companies
Tarsier Pharma Ltd is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet needs in ocular diseases with underlying inflammatory pathologies. Its dazdotuftide platform technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops and intravitreal injections. The company's Product Candidate Pipeline includes TRS01 and TRS02.